Ivabradine in patients with heart failure: a systematic literature review

Ivabradine in patients with heart failure: a systematic literature review

ABSTRACTBackground: Heart failure is a chronic disease linked with significant morbidity and mortality, and uncontrolled resting heart rate is a risk factor for adverse outcomes. This systematic literature review aimed to assess the efficacy, safety, and patient-reported outcomes (PROs) of ivabradin...

Full description

Bibliographic Details
Main Authors:	Zeba M. Khan, Jean Baptiste Briere, Elzbieta Olewinska, Fatma Khrouf, Mateusz Nikodem
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Journal of Market Access & Health Policy
Subjects:	Heart failure ivabradine systematic review quality of life patient-reported outcomes
Online Access:	https://www.tandfonline.com/doi/10.1080/20016689.2023.2262073

Similar Items

Efficacy and Safety of Ivabradine for Patients With Acute Heart Failure: Meta‐Analysis of Randomized Controlled Trials
by: Jing Han, et al.
Published: (2024-11-01)

Efficacy and safety evaluation of ivabradine in patients with non-ischemic heart failure
by: LIU Ying-xian, SONG Yan-jun, CHEN Wei, LIN Xue, LAI Jin-zhi, LI Jing-yi, WU Wei
Published: (2021-11-01)

Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01)

Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure
by: Korhan Soylu, et al.
Published: (2020-08-01)

Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure
by: Sherief Mansour, et al.
Published: (2011-06-01)

IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

Effectiveness and safety of ivabradine in Chinese patients with chronic heart failure: an observational study
by: Jingmin Zhou, et al.
Published: (2024-04-01)

Early administration of ivabradine in patients admitted for acute decompensated heart failure
by: Teng-Yao Yang, et al.
Published: (2022-11-01)

The role of heart rate and ivabradine in acute heart failure
by: Edoardo Sciatti, et al.
Published: (2019-10-01)

Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function
by: Giuseppe Cocco, et al.
Published: (2013-11-01)

Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
by: Hadeer Eid, et al.
Published: (2020-12-01)

Epidemiologic surveillance on quality of life in patients with systolic heart failure after treatment with the selective heart rate inhibitor ivabradine
by: M Srinivasa Rao, et al.
Published: (2017-01-01)

IF CHANNEL INHIBITOR IVABRADINE AND CHRONIC HEART FAILURE MANAGEMENT: FROM DISCUSSION TO ACTION
by: Yu. M. Lopatin
Published: (2012-08-01)

Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial)
by: Amr Abdin, et al.
Published: (2023-10-01)

The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis
by: Juntao Yang, et al.
Published: (2023-10-01)

DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
by: M. V. Surovtseva, et al.
Published: (2012-12-01)

Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction
by: S. A. Sayganov, et al.
Published: (2010-06-01)

Beneficial effect of ivabradine against cardiovascular diseases
by: Maria Alessandra Gammone, et al.
Published: (2020-03-01)

Ivabradine therapy effectiveness in patients with chronic heart failure, Functional Class III
by: S. G. Kanorskiy, et al.
Published: (2011-04-01)

Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age
by: L. Gómez-Ganda, et al.
Published: (2025-02-01)

Case report: Ivabradine induced Torsades de Pointes
by: Mohit M. Bhagwati, et al.
Published: (2023-01-01)

ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease
by: Hosam Zaky, et al.
Published: (2013-01-01)

Ivabradine – a new agent for coronary heart disease treatment
by: O. A. Maneshina, et al.
Published: (2006-06-01)

IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01)

COMPARATIVE EVALUATION OF THE EFFECT OF COMBINATION THERAPY WITH BISOPROLOL BISOPROLOL MONOTHERAPY AND IVABRADINE ON LEFT VENTRICULAR SYSTOLIC FUNCTION, CENTRAL HEMODYNAMICS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE, WITH MODERATELY REDUCED EJECTION
by: /. Katsytadze
Published: (2015-09-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

Efficacy of ivabradin in combined treatment of patients with postinfarction systolic chronic cardiac failure
by: Anton Valer'evich Potapenko, et al.
Published: (2011-12-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

The effect of ivabradine as part of standard therapy on vascular endothelial function and cardiac electrical instability in patients with post-infarction cardiosclerosis and heart failure
by: A. A. Abdullaev, et al.
Published: (2020-02-01)

Modern opportunities of heart rate regulation in coronary heart disease
by: N. Sh. Zagidullin, et al.
Published: (2013-10-01)

Heart rate-lowering therapy in gout patients with stable coronary artery disease: focus on ivabradine
by: N. N. Kushnarenko, et al.
Published: (2020-08-01)

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
by: Tomoko Inoue, et al.
Published: (2023-03-01)

Use of ivabradine in a critically ill pediatric patient with recalcitrant ectopic atrial tachycardia and complex congenital heart disease
by: Gretchen Hackett, DO, MS, et al.
Published: (2022-06-01)

IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01)

Effect of Ivabradine in Controlling Heart Rate in Patients with Sepsis and Septic Shock: Randomized Control Trails
by: S. M. Muneeb Ali, et al.
Published: (2023-03-01)

Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
by: E. V. Kuleshova
Published: (2009-10-01)

IVABRADINE OUTSIDE THE CLINICAL GUIDELINES: INTEREST OF A PRACTITIONER
by: E. I. Tarlovskaya
Published: (2018-04-01)

Effect of preoperative ivabradine on hemodynamics during elective off-pump CABG
by: Sanjula Virmani, et al.
Published: (2023-01-01)